Home › Castration-Resistant Prostatic Cancer › Connecticut
Castration-Resistant Prostatic Cancer clinical trials in Connecticut
3 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in Connecticut.
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Hartford Hospital, Hartford
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07164443Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Yale New Haven Hospital, New Haven
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
- Yale University, Yale Cancer Center, New Haven
RecruitingPhase 1/2
Ages 18 and older · Men · Updated May 29, 2026 · NCT07258407From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.